These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11882789)

  • 1. Using radiotracers to characterize magnetic resonance imaging contrast agents.
    Tweedle MF
    Invest Radiol; 2002 Mar; 37(3):107-13. PubMed ID: 11882789
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of iron-52 as a radioactive tracer.
    FRANCOIS PE; SZUR L
    Nature; 1958 Dec; 182(4650):1665-7. PubMed ID: 13622606
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast-enhanced magnetic resonance imaging of the liver.
    Van Beers B
    J Belge Radiol; 1997 Dec; 80(6):322. PubMed ID: 9479919
    [No Abstract]   [Full Text] [Related]  

  • 4. Paramagnetic iron (III) MRI contrast agents.
    White DL
    Magn Reson Med; 1991 Dec; 22(2):309-12. PubMed ID: 1812362
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of metalloporphyrins in diagnostic imaging.
    Fawwaz R; Bohdiewicz P; Lavallee D; Wang T; Oluwole S; Newhouse J; Alderson P
    Int J Rad Appl Instrum B; 1990; 17(1):65-72. PubMed ID: 2407694
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging.
    Li Z; Wang SX; Sun Q; Zhao HL; Lei H; Lan MB; Cheng ZX; Wang XL; Dou SX; Max Lu GQ
    Adv Healthc Mater; 2013 Jul; 2(7):958-64. PubMed ID: 23322490
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic transport of magnetic resonance imaging contrast agents. Ferrioxamine B derivatives.
    White DL; Eason RG; Alkire AL; Price DC; Hoener BA; Milco LA; Keen RE; Barnhart JL
    Invest Radiol; 1991 Nov; 26 Suppl 1():S146-7; discussion S150-5. PubMed ID: 1808112
    [No Abstract]   [Full Text] [Related]  

  • 8. MR contrast agents, the old and the new.
    Bellin MF
    Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
    Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
    Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.
    Wang X; Niu D; Wu Q; Bao S; Su T; Liu X; Zhang S; Wang Q
    Biomaterials; 2015; 53():349-57. PubMed ID: 25890733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted contrast agents in MR imaging.
    Gupta H; Weissleder R
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):171-84. PubMed ID: 8673713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.
    Shen Z; Wu A; Chen X
    Mol Pharm; 2017 May; 14(5):1352-1364. PubMed ID: 27776215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contrast agents in MRT. Substance, effects, pharmacology and validity].
    Reimer P; Vosshenrich R
    Radiologe; 2004 Mar; 44(3):273-83. PubMed ID: 15287365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis and relaxation properties.
    Rongved P; Klaveness J
    Carbohydr Res; 1991 Jul; 214(2):315-23. PubMed ID: 1769023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro discrimination of triple tracers.
    Bishara BA; Saif M
    J Egypt Med Assoc; 1975; 58(3-4):167-76. PubMed ID: 1223196
    [No Abstract]   [Full Text] [Related]  

  • 17. The spleen: diagnosis of splenic diseases using radiolabeled tracers.
    Spencer RP; Gupta SM
    Crit Rev Clin Lab Sci; 1989; 27(4):299-318. PubMed ID: 2675910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental bases of nuclear cardiology].
    Cuarón Santisteban A
    Arch Inst Cardiol Mex; 1982; 52(6):517-28. PubMed ID: 6760825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octapod iron oxide nanoparticles as high-performance T₂ contrast agents for magnetic resonance imaging.
    Zhao Z; Zhou Z; Bao J; Wang Z; Hu J; Chi X; Ni K; Wang R; Chen X; Chen Z; Gao J
    Nat Commun; 2013; 4():2266. PubMed ID: 23903002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paramagnetic complexes of manganese(II), iron(III), and gadolinium(III) as contrast agents for magnetic resonance imaging. The influence of stability constants on the biodistribution of radioactive aminopolycarboxylate complexes.
    Fornasiero D; Bellen JC; Baker RJ; Chatterton BE
    Invest Radiol; 1987 Apr; 22(4):322-7. PubMed ID: 3583652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.